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Mortality due to oral and 
oropharyngeal cancer in Uruguay 
from 1997 to 2014
Oral and oropharyngeal cancer is considered a public health problem in 
several countries due to its high incidence and mortality rate. Objective: 
This study aimed to analyze oral and oropharyngeal cancer mortality in 
Uruguay from 1997 to 2014 by age, sex and country region. Methodology: 
A time series ecological study using secondary data was performed. Data 
on mortality due to oral and oropharyngeal cancers were obtained from the 
Vital Statistics Department of Uruguay's Ministry of Public Health. Results: 
The cumulative mortality rate due to oral and oropharyngeal cancer over the 
study period was of 19.26/100,000 persons in women and 83.61/100.000 in 
men, with a mean annual rate of 1.75/100,000 in women and 7.60/100,000 
in men. Mortality rate from both sites during the study period was 4.34 times 
higher in men than in women. Malignant neoplasms of other parts of the 
tongue and base of tongue showed the highest mortality rate. The means 
of the annual coefficients of deaths were higher for the age groups between 
50 and 69 years. Higher mortality rates of oral and oropharyngeal cancer 
were observed in Artigas (4.63) and Cerro Largo (3.75). Conclusions: Our 
study described a high mortality rate for oral and oropharyngeal cancer in 
Uruguay from 1997 to 2014. According to the country’s health department, 
men, tongue cancer, and oral cavity had higher mortality rates, with some 
variation. Prevention strategies with control of risk factors and early diagnosis 
are necessary to improve survival in the Uruguayan population.
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Introduction
Head and neck squamous cell carcinoma (HNSCC) 
is in the group of malignant tumors originated in the 
oral cavity, oropharynx, hypopharynx, and larynx.1 
According to the International Agency for Research 
on Cancer (IARC), HNSCC affected more than half 
a million people in 2012, and, of these, 300,373 
cases were oral squamous cell carcinoma (OSCC).2 
An estimate of 325,000 deaths have been annually 
attributed to HNSCC around the world.3 
OSCC is considered a serious public health problem 
in several countries due to its high incidence and 
mortality rate.1,4 Several factors increase the OSCC 
development risk and seem to act by increasing the 
rates of cellular mutation. Exogenous factors related to 
lifestyle, especially tobacco and alcohol consumption, 
seem to be particularly important. HPV infection is 
usually associated with oropharyngeal cancer as well.5
Uruguay is a South American country, which 
is home to 3,286,314 million people and 43% of 
the population live in the capital, Montevideo.6 The 
National Cancer Program of Uruguay published their 
survey of cancer (2007 to 2011) and showed that 
oropharyngeal cancer is the seventh most common 
cancer in the country. It showed a higher incidence in 
men (n=1,079 cases) and a rate of 10.33 cases per 
100,000 men and 2.76 cases per 100,000 women. In 
the capital, 468 cases occurred in men, equivalent to 
11.37 per 100,000 men, and 201 cases in women, 
accounting for 2.99 cases per 100,000 women.7 A 
study performed by Oliveira, et al.8 (2015) analyzing 
the profile of the primary oral squamous cell carcinoma 
(OSCC) in Uruguay found that the male:female ratio 
was 3.8:1, the average age was 60.75 years (±11.26) 
for the population studied, and 42.5% of the cases 
occurred on the tongue. The study concluded that 
OCCS diagnosis in Uruguay is at late stages, with a 
poor prognosis and low survival rate.
In Uruguay between 2004-2008, the mortality 
rate for oral and pharynx cancer was 6.46/100,000 
in men and 1.16/100,000 in women.9 Until now, no 
study has been completed in Uruguay analyzing both 
sites for a long period of time. Also, understanding 
the behavior of the disease over time is important to 
guide public health policies directed towards screening, 
to monitor the results of therapies used and establish 
epidemiological surveillance and control of oral 
and oropharyngeal cancer. Studies that specifically 
analyze these regions are non-existent in Uruguay. 
Thus, this study aimed to assess the rate of oral and 
oropharyngeal cancer mortality in Uruguay and its 
rates by age, sex, and regions of the country.
Methodology
This is a descriptive ecological study using 
secondary data. Data on mortality due to oral and 
oropharyngeal cancer between 1997 and 2014 were 
obtained from the Vital Statistics Department of 
Uruguay’s Ministry of Public Health. The year 2011 
was not analyzed, since no data was available due 
to problems in the national register. The data about 
sociodemographic factors of the Uruguayan population 
were obtained from the National Statistics Institute 
of Uruguay, in 2011. This study was approved by the 
Research Ethics Committee of the School of Dentistry 
of the University of the Republic, Uruguay (358/16).
The data analyzed in this study included deaths 
caused by oral and oropharyngeal cancers. The 
anatomical sites of the neoplasms were determined by 
the International Classification of Diseases, according 
to the codes used in the 10th revision (ICD-10) and 
have been in use since 1994. This study included 
Categories C00 to C10: 
C00 – Malignant Neoplasm of Lip;
C01 – Malignant Neoplasm of Base of Tongue;
C02 – Malignant Neoplasm of Other and Unspecified 
Parts of Tongue;
C03 – Malignant Neoplasm of Gum;
C04 – Malignant Neoplasm of Floor of Mouth;
C05 – Malignant Neoplasm of Palate;
C06 – Malignant Neoplasm of Other and Unspecified 
Parts of Mouth;
C07 – Malignant Neoplasm of Parotid Gland;
C08 – Malignant Neoplasm of Other and Unspecified 
Major Salivary Glands;
C09 – Malignant Neoplasm of Tonsil and
C10 – Malignant Neoplasms of the Oropharynx
Uruguay has 19 regions or provinces: Artigas, 
Canelones, Cerro Largo, Colonia, Durazno, Flores, 
Florida, Lavalleja, Maldonado, Montevideo, Paysandu, 
Rio Negro, Rivera, Rocha, Salto, San Jose, Soriano, 
Tacuarembo and Treinta y Tres. This study analyzed 
mortality trends in each of them.
All mortality rates (number of deaths related to oral 
and oropharyngeal cancers per 100,000 inhabitants) 
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analyzed and showed in this study were standardized 
by sex and age groups (15 to 19 years; 20 to 29 years; 
30 to 39 years; 40 to 49 years; 50 to 59 years; 60 
to 69 years; 70 to 79 years and 80 years or more), 
using the direct method, taking as reference the world 
population in 2011, adopting the “Dell STATISTICA” 
software package. Standardization was used with the 
objective of accounting for and removing the effects 
of factors related to the distribution of disease in the 
population that may interfere in the risk of mortality 
by oral and oropharyngeal cancer in the Uruguayan 
population (for example, sex distribution). Mean 
annual mortality rates represent the standardized 
arithmetic mean of annual mortalities rates from 1997 
to 2014. All rates were multiplied by 100,000.
Results
Between 1997 and 2014, 1,696 deaths from 
oral and oropharyngeal cancers were reported in 
Uruguay. The cumulative mortality rate due to oral 
and oropharyngeal cancer over the study period was of 
19.26/100,000 persons in women and 83.61/100.000 
men, with a mean annual rate of 1.75/100,000 in 
women and 7.60/100,000 in men.
The deaths were distributed into five categories, 
according to the anatomical site of the tumor: lip 
cancer (C00), tongue cancer (C01 and C02), oral cavity 
cancer (C03, C04, C05 and C06), salivary gland cancer 
(C07 and C08) and oropharyngeal cancer (C09 and 
C10). Table 1 shows the distribution of the deaths from 
1997 to 2014, considering these five categories, and 
the ratio between the male and female crude mortality 
rates, for each category and total. The ratio between 
male and female rates was 3.23:1, the lowest ratio 
was for salivary gland cancer (1.83:1) and the highest 
ratio was for oropharyngeal cancer (6.40:1).
The proportional distribution by anatomical site 
of the deaths from oral and oropharyngeal cancers 
showed that malignant neoplasms of other and 
unspecified parts of the tongue (C02) represented 
25.88% of cases, followed by malignant neoplasms of 
the base of the tongue (C01), with 13.18%. Malignant 
neoplasm of the gum (C03) and malignant neoplasm 
of other and unspecified major salivary glands (C08) 
showed the lowest mortality rates.
For each anatomical site, the absolute and relative 
frequencies of deaths from 1997 to 2014 and the 
mean of the annual coefficients adjusted for sex and 
age (annual mortality rate per 100,000 inhabitants) 
are presented. The oral cavity has been considered 
a site that included other parts of the tongue, gums, 
floor of the mouth, palate, other parts of the mouth 
and salivary glands. In is this study, all  oral cavity 
sub-sites represented 1,080 (63.70%) of deaths. 
Oropharyngeal cancer included the sub-sites, as 
described by WHO, such as the base of the tongue, 
tonsils and oropharynx and was responsible for 616 
(36.30%) deaths (Table 2).
Table 3 shows that the mean of the annual 
coefficients and the (cumulative) coefficients for the 
whole period, adjusted for sex and age group (per 
100,000 inhabitants), for females and males and 
the proportion between these (M/F) coefficients for 
the period. The  mortality rate from oral cavity and 
oropharyngeal cancer for the study period was 4.34 
times higher in men than in women. Considering each 
of the anatomical sites, the mean of M/F ratios for the 
period was 4.70. The only site where the rate was 
higher for females was site C08 (malignant neoplasms 
of other and unspecified major salivary glands), in 
which it was 0.94. All sites of oropharyngeal cancer 
(base of the tongue, tonsils, and oropharynx) had 
M/F rate up to nine (mean of 9.16). Oral cavity sites 
exhibited a lower M/F rate with a mean of 3.02.
For the 20-29 age group, it was observed that 
no cases were reported before 2004. Table 4 shows 
the absolute and relative frequencies of deaths from 
1997 to 2014 (excluding 2011, since that data was 
Anatomical site Number of deaths (%) F M Ratio
Lip cancer        32                (1.88) 7 25 3.57
Tongue cancer       664               (39.06) 157 507 3.23
Oral cavity cancer (excluding tongue and lip)       410               (24.12) 114 296 2.60
Salivary gland cancer       198               (11.65) 70 128 1.83
Oropharyngeal cancer       392               (23.06) 53 339 6.40
Total     1,696              (100) 401 1,295 3.23
Table 1- Death distribution from oral and oropharyngeal cancer, according to the tumor anatomical site and sex of the subjects, Uruguay, 
1997-2014
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not available due to a failure in the database) for each 
age group and the average of the annual coefficients 
adjusted by sex and age group (per 100,000 
inhabitants). The means of the annual coefficients 
were higher for the age groups between 50 and 79 
years. The mean of the annual coefficients and the 
(cumulative) coefficients for the whole period, adjusted 
for sex and age group (per 100,000 inhabitants) was 
2.74 in women and 11.94 in men for each age group 
and the proportion between these (M/F) coefficients 
for the period was 4.84. (Table 4). The mortality 
rates by oral and oropharyngeal cancers during the 
study period was 4.34 times higher in men than in 
women and the age group between 40-49 years had 
the highest M/F coefficient (10.88), followed by the 
50-59 group (8.50).
Regarding the distribution for regions in the 
country, the time series of annual coefficients, adjusted 
by sex and age group (annual mortality rate per 
100,000 inhabitants) from 1997 to 2014, showed a 
decrease in the rates in Artigas and Rivera in the total 
population and in men. In addition, in Flores, periods 
of high rates alternated with periods of zero rate. The 
absolute and relative frequencies of deaths in the 
study period, for each region and the average of the 
annual coefficients adjusted by sex and age group 
(per 100,000 inhabitants), showed that mean annual 
coefficients of deaths vary from 2.09, in Rocha, to 4.63 
Anatomical site F - Mean M - Mean F – Cumulative M -Cumulative M/F
Lip 0.02 0.09 0.31 1.48 4.83
Base of the tongue 0.08 0.77 1.43 13.11 9.15
Other parts of the tongue 0.37 1.18 6.34 20.14 3.18
Gums 0.01 0.02 0.16 0.38 2.43
Floor of mouth 0.13 0.56 2.15 9.52 4.44
Palate 0.09 0.26 1.56 4.46 2.86
Others parts of the mouth 0.09 0.27 1.51 4.67 3.09
Parotid gland 0.18 0.42 3.00 7.21 2.40
Other major
salivary glands 0.02 0.02 0.38 0.35 0.94
Tonsils 0.07 0.66 1.20  11.26 9.36
Oropharynx 0.07 0.65 1.23  11.03 8.97
Total - -   19.26   83.61 4.34
Mean - - 1.75 7.60   4.70*
NOTE: * This value refers to the average of the ratios M/F and not to the proportion of the average values of the coefficients for females 
(1.75) and males (7.60)
Table 3- Mortality by cancers of the oral cavity and oropharynx, according to anatomical site and sex (F = Female, M = Male), Uruguay, 
1997-2014
Anatomical site Number of deaths % Mean of the annual 
coefficients
Lip 32 1.88 0.05
Base of the tongue 224 13.18 0.43
Other parts of the tongue 440 25.88 0.78
Gums 9 0.53 0.02
Floor of the mouth 187 11.00 0.34
Palate 107 6.29 0.18
Other parts of the mouth 107 6.29 0.18
Parotid gland 186 10.94 0.30
Other major salivary glands 12 0.71 0.02
Tonsils 198 11.65 0.37
Oropharynx 194 11.41 0.36
Total 1,696 100.00
Table 2- Mortality by oral and oropharyngeal cancer, according to the anatomical site, Uruguay, 1997-2014. Absolute and relative 
frequencies of deaths and an average of the coefficients annually adjusted by sex and age (by 100,000 inhabitants)
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in Artigas. Montevideo represented 44.10% of the 
deaths in the period, but the average annual mortality 
rate for this region was 3.21 deaths per 100,000 
inhabitants. Montevideo is where approximately half 
of the country’s population lives. This means that for 
the whole (cumulative) period, adjusted by sex and 
age group (per 100,000 inhabitants) are shown in 
Table 5, which revealed a value of 16.72 in women 
and 79.82 in men, making the male/female proportion 
of 5.22. Artigas showed the highest M/F ratio (12.53) 
followed by Cerro Largo (10.01), the lowest ratio was 
in Florida (2.24), where the cumulative coefficient in 
women was 31.90 and in men was 71.35.
Discussion
To understand the mortality rate due to oral and 
oropharyngeal cancers for a population may influence 
new strategies to improve prevention and promote 
early diagnosis policies for these diseases. This study 
is the first one that assess, over a long period of 
time, the mortality rate by oral and oropharyngeal 
cancer in Uruguay according to sex, age, anatomic 
site, and geographical distribution. In general, our 
main findings reveal higher mortality rates in cases of 
oral cavity cancer compared to oropharyngeal cancer. 
Tongue cancer affecting men who live in the capital 
of the country showed the highest rates of mortality 
Age Group   Deaths (%) F – Mean M – Mean F – Cumulative M – Cumulative M/F
15 |- 20      1        (0.06) 0.01 - 0.09 - -
20 |- 30      8        (0.47) 0.02 0.03 0.27 0.48 1.76
30 |- 40      16      (0.94) 0.02 0.06 0.42 0.98 2.34
40 |- 50      99      (5.84) 0.04 0.47 0.73 7.94 10.88
50 |- 60     365     (21.52) 0.18 1.51 3.02 25.72 8.50
60 |- 70     490     (28.89) 0.27 1.53 4.52 25.97 5.75
70 |- 80     407     (24.00) 0.27 0.92 4.58 15.68 3.43
80 |-     310     (18.28) 0.33 0.40 5.63 6.84 1.22
Mean    1.696   (100) 2.74 11.94 4.84
Table 4- Mortality by oral and oropharyngeal cancer, for each group age, Uruguay, 1997-2014
Department    F – Mean M – Mean F – Cumulative M – Cumulative       M/F
Artigas 0.69 8.59 11.66 146.02 12.53
Canelones 1.22 4.96 20.70 84.24 4.07
Cerro Largo 0.68 6.82 11.58 115.95 10.01
Colonia 0.89 3.80 15.16 64.55 4.26
Durazno 0.96 3.53 16.30 59.98 3.68
Flores 1.03 4.75 17.54 80.78 4.61
Florida 1.88 4.20 31.90 71.35 2.24
Lavalleja 1.09 4.73 18.45 80.40 4.36
Maldonado 0.74 4.81 12.56 81.76 6.51
Montevideo 1.26 5.16 21.41 87.69 4.10
Paysandu 0.98 4.43 16.71 75.35 4.51
Rio Negro 1.05 5.06 17.84 86.07 4.82
Rivera 0.66 4.05 11.24 68.88 6.13
Rocha 0.96 3.22 16.28 54.68 3.36
Salto 1.12 4.02 18.99 68.41 3.60
San Jose 0.68 5.01 11.61 85.20 7.34
Soriano 0.73 3.47 12.45 58.92 4.73
Tacuarembo 1.02 5.07 17.34 86.24 4.97
Treinta y Tres 1.06 3.54 18.03 60.14 3.34
Total - - 16.72 79.82 5.22
Table 5- Mortality by oral and oropharyngeal cancer, according to department and sex (F = Female, M = Male), Uruguay, 1997-2014
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in the study. 
Our results found that of 1.696 deaths registered in 
the study period, the oral cavity (63.70%) was more 
affected than the oropharynx (36.30%). This differs 
from the study published by Perea, et al.10 (2018), 
which revealed more deaths due to pharyngeal cancer 
than oral cavity cancer in Brazil, but when tonsils and 
oropharyngeal (except for the base of the tongue) 
cancers were considered, the average was similar 
in both regions. In Germany, Hertrampf, et al.11 
(2015) reported that 54% of deaths were related to 
pharyngeal cancer, 40% to oral cavity cancer and 6% 
due to salivary gland cancer. Explaining the differences 
among our results and other studies is difficult, but one 
possible hypothesis is that Brazil and Germany have 
more effective strategies for oral cancer prevention 
or early diagnosis that impact the mortality rates for 
pharyngeal cancer.
We observed that tongue cancer was related to 
higher rates of mortality, since 440 cases of cancer 
were reported in the oral cavity and 224 cases in 
the oropharynx. These results agree with the data 
described by Oliveira, et al.8 (2015), which found 
that, in Uruguay, oral cancer is more prevalent on 
the tongue and its diagnosis tend to be at a later 
stage. Other studies also showed a higher mortality 
for tongue cancer, varying between 20% to 50% of 
cases.12,13 Several studies suggested that lack of oral 
examinations, late diagnosis and advanced stage of 
the diseases were the main causes of higher mortality 
rates associated with tongue tumors.14-15 Moreover, 
tongue tumors usually cause early metastases in the 
lymph nodes, promoting an increase in the mortality 
rate.16
The death rates between men and women have 
been studied extensively.17-20 Most countries estimate 
oral and oropharyngeal cancer mortality to be 3-4 per 
100,000 men and 1.5-2 per 100,000 women at age-
adjusted rates, and studies often indicate that women 
have a higher survival rate than men.1,21 Our results 
showed that deaths from oral and oropharyngeal 
cancers in Uruguay during 1997-2014 were 4.34 
times greater in males than in females. These findings 
confirm previous studies worldwide.1,17,19,22 However, 
our male-female ratio was slightly higher than the 
ratio of other studies conducted in the region; Chile, 
for instance, varies between 2.8:1 and 2.3:1.22,23 In 
addition, correlating theses aspects with other risk 
factors such as tobacco and alcohol consumption 
in Uruguay is important. In 2014, the National 
Statistical Institute of Uruguay reported that 27.0% 
of men over 15 years old use tobacco compared to 
17.9% of women.24 The May 2014 report from the 
National Cancer Registry indicated that the rates 
observed between 1990 and 2012 increased in both 
sexes, and this increase is considered significant in 
women.7 Perea, et al.10 (2018) suggested that another 
explanation for the differences between the sexes is 
that women tend to have regular dental appointments, 
which can improve their earlier diagnosis of oral cancer.
Analyzing the mortality related to an anatomical 
site found an increase up to a 9.0 in the M/F death 
ratio in sites like the base of the tongue, tonsils, and 
oropharynx. This modification can be associated to 
risk factors. Although our study did not assess risk 
factors associated to oropharyngeal cancer, it is 
important to discuss that besides tobacco and alcohol 
exposure, other aspects such as HPV infection and 
mate consumption have been reported. HPV infection 
has been associated to epidemiological and mortality 
rate modification in oropharyngeal cancer, especially in 
tonsils.25-26 An increase in incidence and an improved 
prognosis of HPV-positive tumors has been reported.27 
In addition, mate consumption, which is a common 
habit in Uruguayan population, have been associated 
to an increased risk for oral cancer. It probably occurs 
due to the combination of the beverage temperature 
and its chemical composition.28 New studies involving 
the analysis of all risk factors should be performed to 
better analyze their connection with oropharyngeal 
cancer epidemiology and mortality.
This research identified differences among 
country regions. The higher mortality rates of oral 
and oropharyngeal cancer were observed in Artigas 
(4.63) and Cerro Largo (3.75). These results are in 
accordance with the study carried out by Barrios, et al. 
in Uruguay for the period of 2004-2008 that showed 
that Artigas, Cerro Largo y San Jose had mortality 
rates of up to 9/100,000 in men, while in women the 
highest rates were in Salto y Treinta y Tres.9 However, 
our results revealed that the mortality rates in Artigas 
and Rivera were higher, but they have been decreasing 
during the 17 years of our study evaluation time. Both 
regions are bordering the southern portion of Brazil 
and could be exposed to Brazilian policies on cancer 
prevention and early diagnosis strategies. Perea, et 
al.10 (2018) analyzed trends for oral and oropharyngeal 
cancer in all macro-regions of Brazil, finding an overall 
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decrease in the South and Southern regions, possibly 
due to their anti-smoking policies. The development 
of preventive actions focusing on early detection and 
diagnosis in individuals at risk, particularly within the 
scope of primary health care, may be key in reducing 
mortality due to oral and oropharyngeal cancers.
This study is based on secondary information 
data registered with the National Statistics Institute 
of Uruguay. This type of study design has limitations 
because it is dependent on the accuracy and 
completeness of available information systems. 
Another limitation is related to the study design. 
Ecological studies are useful for raising hypotheses; 
however, they are not able to provide information 
about causality. According to IARC-WHO evaluation 
of registry data worldwide, the registry tracking 
the incidence of cancer in Uruguay is a high quality 
instrument, while mortality information is classified 
as medium quality registration data.
Conclusions
Our results found that mortality due to oral cancer 
is higher than oropharyngeal cancer. In both sites, 
tongue cancer, men, and adults between 50 and 69 
years  old showed higher mortality rates. Improving 
the control of risk factors, mainly tobacco and alcohol, 
investigating HPV-status and implementing strategies 
for prevention and early diagnosis of these lesions is 
important. 
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13- Anaya-Saavedra G, Ramírez-Amador V, Irigoyen-Camacho 
ME, Zimbrón-Romero A, Zepeda-Zepeda MA. Oral and pharyngeal 
cancer mortality rates in Mexico, 1979-2003. J Oral Pathol Med. 
2008;37(1):11-7. 
14- Naseer R, Naz I, Mahmood MK. Frequency of delayed diagnosis 
of oral squamous cell carcinoma in Pakistan. Asian Pac J Cancer Prev. 
2016;17(11):5037-50.
15- Jafari A, Najafi SH, Moradi F, Kharazifard MJ, Khami MR. Delay 
in the diagnosis and treatment of oral cancer. J Dent (Shiraz). 
2013;14(3):146-50. 
16- Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 
2015;8(9):11884-94.
17-  Perdomo S, Martin Roa G, Brennan P, Forman D, Sierra MS. Head 
and neck cancer burden and preventive measures in Central and South 
America. Cancer Epidemiol. 2016;44 Suppl 1:S43-S52.
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